BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:AZD6793 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of AZD6793\, from ClinicalTrials.gov estimat
 es.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07082738-11161@assetmemo.bio
DTSTAMP:20261121T004547Z
DTSTART;VALUE=DATE:20270831
DTEND;VALUE=DATE:20270901
SUMMARY:AZD6793: Phase 2 readout est. (NCT07082738)
DESCRIPTION:AZD6793\, phase 2\, Chronic Obstructive Pulmonary Disease.\nStu
 dy: A Study to Investigate the Effect of AZD6793 in Participants With Mode
 rate to Very Severe Chronic Obstructive Pulmonary Disease\nEstimated prima
 ry completion: 31 August 2027. This is a ClinicalTrials.gov estimate\, not
  a confirmed readout date\, and it can move.\nDrug page: https://assetmemo
 .bio/drug/azd6793#upcoming-events\nRegistry record: https://clinicaltrials
 .gov/study/NCT07082738
URL:https://assetmemo.bio/drug/azd6793#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
